IAM1363

· Iambic Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IAM1363, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/1b Study of IAM1363 in HER2 Cancers [Phase 1]